ClinVar Miner

Submissions for variant NM_000317.3(PTS):c.166GTG[1] (p.Val57del)

dbSNP: rs770387277
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000666747 SCV000791097 likely pathogenic 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency 2017-04-21 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000666747 SCV001580128 pathogenic 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency 2023-08-31 criteria provided, single submitter clinical testing Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Experimental studies have shown that this variant affects PTS function (PMID: 7493990). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 551630). This variant has been observed in individual(s) with 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency (PMID: 7493990, 11438997, 30926181). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs770387277, gnomAD 0.008%). This variant, c.169_171del, results in the deletion of 1 amino acid(s) of the PTS protein (p.Val57del), but otherwise preserves the integrity of the reading frame. For these reasons, this variant has been classified as Pathogenic.
Genome-Nilou Lab RCV000666747 SCV002014500 likely pathogenic 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency 2021-09-05 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000666747 SCV002024771 likely pathogenic 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency 2021-06-08 criteria provided, single submitter clinical testing
Baylor Genetics RCV000666747 SCV004207149 pathogenic 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency 2024-02-29 criteria provided, single submitter clinical testing
Natera, Inc. RCV000666747 SCV002075540 pathogenic 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency 2020-04-14 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.